#paperhighlights Jun2021 #2

Multivalency transforms SARS-CoV-2 antibodies into ultrapotent neutralizers

Rujas E, Kucharska I, Tan YZ, Benlekbir S, Cui H, Zhao T, Wasney GA, Budylowski P, Guvenc F, Newton JC, Sicard T, Semesi A, Muthuraman K, Nouanesengsy A, Aschner CB, Prieto K, Bueler SA, Youssef S, Liao-Chan S, Glanville J, Christie-Holmes N, Mubareka S, Gray-Owen SD, Rubinstein JL, Treanor B, Julien JP

Nat Commun. 12(1):3661 (2021)

doi: 10.1038/s41467-021-23825-2